Status:
TERMINATED
Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Burn Wound
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
This pilot study aims to assess the feasibility of providing immunonutrition supplementation to older burn patients (age 55 and older) and its impact on burn wound healing. Supplements containing argi...
Detailed Description
Studies performed previously in burn patients have had mixed patient cohorts with small sample sizes and these have failed to show any large improvements in wound healing. However, in older population...
Eligibility Criteria
Inclusion
- Subject has partial of full thickness thermal injury of 1-15% of total body surface area (TBSA)
- Subject has an inpatient admission for their burn
- Subject or authorized decision maker understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator
Exclusion
- Subject with inhalation injury and/or intubation
- Subject receiving immunosuppressive medications including chronic steroids, immune modulating medications, and chemotherapy prior to admission
- Subject with pre-existing severe chronic liver disease or end stage renal disease
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04725071
Start Date
July 1 2022
End Date
September 9 2024
Last Update
November 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792